Welcome to LookChem.com Sign In|Join Free
  • or
(4-Chlorophenyl)(4-(beta-D-glucopyranosyloxy)phenyl)methanone hemihydrate is a chalcone derivative chemical compound with the molecular formula C20H17ClO7·0.5H2O. It features a chlorophenyl group and a glucopyranosyloxyphenyl group attached to a central methanone molecule and exists in a hemihydrate form with partially bound water molecules within its crystal lattice. (4-Chlorophenyl)(4-(beta-D-glucopyranosyloxy)phenyl)methanone hemihydr ate holds potential pharmaceutical and medicinal applications due to its anti-inflammatory, antioxidant, and anticancer properties, making it a promising candidate for drug development and research in the fields of medicine and pharmacology.

83355-63-9

Post Buying Request

83355-63-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

83355-63-9 Usage

Uses

Used in Pharmaceutical Industry:
(4-Chlorophenyl)(4-(beta-D-glucopyranosyloxy)phenyl)methanone hemihydrate is used as a pharmaceutical compound for its anti-inflammatory properties, helping to reduce inflammation in the body and alleviate related symptoms.
Used in Medicinal Applications:
In the medicinal field, (4-Chlorophenyl)(4-(beta-D-glucopyranosyloxy)phenyl)methanone hemihydrate is used as an antioxidant agent, protecting cells from damage caused by free radicals and potentially reducing the risk of various diseases associated with oxidative stress.
Used in Anticancer Research:
(4-Chlorophenyl)(4-(beta-D-glucopyranosyloxy)phenyl)methanone hemihydrate is used as an anticancer agent, exhibiting potential in targeting and inhibiting the growth of cancer cells. Its unique structure allows it to interact with cellular proteins and enzymes, making it a valuable compound for further research and development in cancer treatment.
Used in Drug Development:
(4-Chlorophenyl)(4-(beta-D-glucopyranosyloxy)phenyl)methanone hemihydr ate is used as a candidate in drug development due to its promising properties and potential applications in medicine and pharmacology. Its ability to interact with cellular proteins and enzymes makes it a valuable starting point for the creation of new drugs targeting various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 83355-63-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,3,5 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 83355-63:
(7*8)+(6*3)+(5*3)+(4*5)+(3*5)+(2*6)+(1*3)=139
139 % 10 = 9
So 83355-63-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H19ClO7/c20-12-5-1-10(2-6-12)15(22)11-3-7-13(8-4-11)26-19-18(25)17(24)16(23)14(9-21)27-19/h1-8,14,16-19,21,23-25H,9H2/t14-,16-,17+,18-,19-/m1/s1

83355-63-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (4-chlorophenyl)-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methanone

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83355-63-9 SDS

83355-63-9Downstream Products

83355-63-9Relevant academic research and scientific papers

Glycosylated Derivatives of Benzophenone, Benzhydrol, and Benzhydril as Potential Venous Antithrombotic Agents

Bellamy, Francois,Horton, Derek,Millet, Jean,Picart, Francois,Samreth, Soth,Chazan, Jean Bernard

, p. 898 - 903 (2007/10/02)

A series of glycosylated derivatives of benzophenone, benzhydrol, and benzhydril has been synthesized and evaluated for potential activity as venous antithrombotic agents.Studies on structure-activity relationships revealed that compounds having an electr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 83355-63-9